Teslas Latest Software Update Targets Competitive Pressures in China Market Amazons Fashion Ambitions Deepen Met Gala Controversy Highlights Big Techs Growing Influence in Luxury Borosil Glass Works Sees Stellar Rally of Over 200 in One Year Barnes Noble CEO James Daunt Clarifies Stance on AIGenerated Books A Straightforward Rejection of AI Books Trump Signals Progress on Iran Nuclear Deal Strait of Hormuz Reopening in Focus David Einhorns Hedge Fund Greenlight Capital Takes Bullish Stance on Major Mall Retail Stock CBNA Q1 2026 Earnings EPS Surpasses Estimates Despite Stock Pullback GEOS Q1 2026 Earnings Loss Reported Amid Challenging Market Conditions ETSY Q1 2026 Earnings EPS Surges 409 Above Estimates Shares Climb SLXN Q1 2026 Earnings NarrowerThanExpected Loss Highlights Cost Discipline Coeur Mining CDE Q1 2026 Earnings EPS Miss Highlights Cost Pressures on Bottom Line GOODO Q1 2026 Earnings Preferred Stock Rises as EPS Surges Past Estimates Haemonetics HAE Surges 573 to 6549 Testing Key Resistance Levels Cognition Therapeutics Inc CGTX Slips Modestly as Stock Hovers Near Support Zone Collegium Pharmaceutical COLL Holds Near Resistance After Slight Decline Rising Dragon Acquisition Corp RDAC Holds Steady Near 930 Amid SPAC Uncertainty B2Gold Corp BTG Holds Steady Near Support as Gold Prices Fluctuate Caribbean Beachfront Development Local Access Rights vs Foreign Real Estate Investment FINV Q4 2025 Earnings EPS Reported at 172 Stock Declines Amid Incomplete Disclosure Lucky Strike Entertainment LUCK Edges Higher on Modest Volume Key Resistance in Focus US Official Alleges Japans Role in Fentanyl Smuggling Raising Trade and Compliance Concerns Infrastructure Control Emerges as Potential Next Frontier for Competitive Advantage US Government Stakes in Quantum Firms Spark Speculation IonQ Micron Anduril Next Lidl Overtakes Morrisons to Become UKs FifthLargest Supermarket JPMorgan CEO Dimon Indicates Shift Toward AI Hiring Fewer Traditional Bankers Microsoft and Anthropic in Advanced Talks for Maia AI Chip Supply Deal After 5 Billion Investment AI May Accelerate Discovery of Treatments for Brain Disorders Like MND